Company Data
Genenta Science S.p.A.
Ticker
GNTA
Current Price
$0.69 -3.29%
Market Cap
$16.3M
Price Target
Refer to Report
Volume
34.8K
52wk Range
$0.59 - $10
Overview
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company’s product under development includes Temferon – a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.